16th Annual Coastal Dermatology Symposium

16th Annual Coastal Dermatology Symposium is organized by Global Academy for Medical Education, LLC. This Online CME Course will commence from Oct 15 - 16, 2020.

How many CME credits can be earned by attending the 16th Annual Coastal Dermatology Symposium?

Accreditation:
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians will be able to earn the credit commensurate based on the extent of their participation in the activity.

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 13.5 contact hours. Pharmacotherapy contact hours for Advanced Practice Nurses will be assigned on your certificate.

Session Details:
Live General Sessions: October 15-16, 2020
Live Session 1: October 15, 2020 5:55 PM - 9:00 PM
Live Session 2: October 16, 2020 11:30 AM - 7:00 PM

What is the significance of the 16th Annual Coastal Dermatology Symposium?

Course Description:
The Coastal Dermatology Symposium is intended to produce high-quality continuing medical education highlighting the latest updates in medical dermatology and the diagnosis and treatment of various dermatological conditions. The educational online CME webcast yields the content that is of interest to practicing dermatologists, dermatology residents, internists, family practitioners, physician assistants, nurse practitioners, nurses, and other healthcare professionals who treat diseases of the skin.

For the 16th Annual Coastal Dermatology Symposium, an internationally-known faculty and eminent thought leaders will proffer in-depth education and stimulate audience discussion on topics including Acne, Eczema, Rosacea, Psoriasis, Hyperhydrosis, AKs vs. Warts, Atopic Dermatitis, Photodermatoses, Dermatomyositis, and Cutaneous Lupus.

What are the benefits of attending the 16th Annual Coastal Dermatology Symposium?

Learning Objectives:
At the conclusion of this Online CME Course, participants should be better able to:
Rosacea, Acne, Contact Dermatitis
• Produce a comprehensive treatment plan for acne, rosacea, and contact dermatitis based on clinical guidelines and incorporating pharmacological and non-pharmacological therapies.

Actinic Keratosis (AKs) vs Warts
• Recognize the similarities in the pathogenesis, histology, and clinical presentations of warts and actinic keratosis in terms of potential targets for therapy.
• Explain the treatment algorithms currently in practice in the dermatology community and how they can be translated to approaching patients with both conditions.

Autoimmune Skin Diseases
• Produce a strategy for identifying cutaneous adverse reactions while treating rheumatic skin diseases.
• Recognize the potential side effects of medications used to treat rheumatic skin diseases.

Hyperhidrosis
• Recognize the diagnostic criteria for focal and general hyperhidrosis.
• Examine the mechanisms of action of therapeutic options for hyperhidrosis.

Vaccines
• Identify the differences between old and new versions of HPV and VZV vaccines
• Recognize novel vaccines recently developed and approved for rare, potentially fatal diseases
• Advocate for vaccine construction for pathogens where it has been lacking

Psoriasis
• Diagnose and treat patients with psoriasis properly, based on current clinical guidelines.
• Plan treatment approaches that incorporate of biologic therapies in the management of appropriately selected patients with psoriasis.
• Catalog key patient characteristics to individualize treatment selection in patients with psoriasis.

Pediatric Dermatology
• Describe evolving practices and therapeutics for molluscum in children
• Examine the evolution of systemic and new topical therapies for pediatric atopic dermatitis
• Identify COVID-associated acral erythema in children and changes in practice related to the epidemic

Atopic Dermatology
• Evaluate disease severity and impact of atopic dermatitis on the patient and family
• Define new data on bathing, age indications for non-steroidal medications, and evolving indications and emerging research on topical agents for atopic dermatitis
• Describe emerging systemic therapies and how they may be utilized for moderate to severe atopic dermatitis

Dermatomyositis and Cutaneous Lupus
• Specify lupus from dermatomyositis on clinical grounds.

The Red Face
• Define patients with a “red face” into four major groups
• Recognize the three-common cause of plethora and know the significance of each
• Specify lupus from dermatomyositis on clinical grounds

Photoprotection
• Discuss photoprotection with patients, including pediatric patients and their caregivers.
• Explain the algorithm for the diagnosis of photodermatoses.